Mirapex ER (pramipexole) extended-release

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 ADVERSE REACTIONS Postmarketing Experience Addition of the following paragraph: There are postmarketing reports of...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts